GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human dihydroorotate dehydrogenase (dhodh) with amino-benzoic acid inhibitor 951 at 2.00A resolution

Analyse Crystal structure of human dihydroorotate dehydrogenase (dhodh) with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3KVM
Type
protein
Length
366 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroorotate dehydrogenase, mitochondrial
EC
1.3.5.2
UniProt
Q02127
Ligands
FMN, DOR, DET, 951, SO4
Pockets
4 · best druggability 0.84

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydroorotate dehydrogenase, mitochondrial (EC 1.3.5.2)protein36647% helix, 16% strandQ02127

Ligands and binding sites

  • FMN · Flavin mononucleotide · ligand · chains A
  • DOR · (4S)-2,6-dioxohexahydropyrimidine-4-carboxylic acid · ligand · chains A
  • DET · Undecylamine-N,N-dimethyl-N-oxide · ligand · chains A
  • 951 · 2-[(2E)-2-{[5-(2-chlorophenyl)furan-2-yl]methylidene}hydrazino]benzoic acid · ligand · chains A
  • SO4 · Sulfate ion · ion · chains A
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14060.840.9158FMN, DOR, 951
2840.510.8426empty
3820.470.8219DET
4740.430.8118empty

Compared structures

  • 3KVM · Crystal structure of human dihydroorotate dehydrogenase (DHODH) with amino-benzoic acid… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.